James R Johnson

Author PubWeight™ 209.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2007 7.81
2 Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 2003 4.63
3 Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med 2013 4.55
4 The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol 2007 3.55
5 Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013 2.85
6 The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 2013 2.64
7 Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012 2.60
8 Doxycycline for treatment of community-acquired pneumonia. Clin Infect Dis 2002 2.48
9 Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis 2004 2.40
10 Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2012 2.22
11 Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol 2008 2.02
12 High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012 2.00
13 Complications of Foley catheters--is infection the greatest risk? J Urol 2012 2.00
14 Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc 2006 1.93
15 Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol 2006 1.82
16 Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project. Clin Infect Dis 2011 1.79
17 Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun 2010 1.72
18 Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013 1.72
19 Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med 2009 1.72
20 Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2012 1.69
21 The genetic structure of Escherichia coli populations in primary and secondary habitats. Microbiology 2002 1.67
22 Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol 2011 1.66
23 Food-borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis 2012 1.65
24 Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010 1.60
25 Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol 2004 1.59
26 IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 2002 1.59
27 Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 2004 1.56
28 Loop-mediated isothermal amplification assay for rapid detection of common strains of Escherichia coli. J Clin Microbiol 2008 1.55
29 Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician 2011 1.51
30 Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology 2013 1.49
31 Acquisition of avian pathogenic Escherichia coli plasmids by a commensal E. coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun 2006 1.49
32 Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol 2008 1.49
33 Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005 1.49
34 Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006 1.47
35 Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 2011 1.44
36 Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis. J Clin Microbiol 2009 1.44
37 Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2006 1.40
38 Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother 2013 1.40
39 Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One 2011 1.40
40 Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 2011 1.40
41 Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother 2011 1.36
42 Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005 1.36
43 Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis 2010 1.35
44 Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem 2008 1.34
45 Self-assembly of fluorescent inclusion complexes in competitive media including the interior of living cells. J Am Chem Soc 2007 1.33
46 Selective recognition of bacterial membranes by zinc(II)-coordination complexes. Chem Commun (Camb) 2006 1.33
47 Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem 2005 1.32
48 Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2007 1.32
49 Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 2007 1.29
50 The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob Agents Chemother 2013 1.28
51 Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int J Antimicrob Agents 2010 1.28
52 Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J Clin Microbiol 2013 1.28
53 Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013 1.28
54 Preoperative urine cultures at a veterans affairs medical center. JAMA Intern Med 2013 1.25
55 Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006 1.23
56 Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines 2006 1.21
57 Complete Genome Sequence of the Epidemic and Highly Virulent CTX-M-15-Producing H30-Rx Subclone of Escherichia coli ST131. Genome Announc 2013 1.18
58 Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol 2013 1.17
59 Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect 2008 1.16
60 Enteroaggregative Escherichia coli related to uropathogenic clonal group A. Emerg Infect Dis 2007 1.14
61 Colonization with extraintestinal pathogenic Escherichia coli among nursing home residents and its relationship to fluoroquinolone resistance. Antimicrob Agents Chemother 2004 1.13
62 Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol 2013 1.12
63 The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes. J Nucl Cardiol 2009 1.12
64 Sepsis from the gut: the enteric habitat of bacteria that cause late-onset neonatal bloodstream infections. Clin Infect Dis 2014 1.11
65 Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 2010 1.11
66 Outcomes of a Hepatitis C screening program at a large urban VA medical center. J Clin Gastroenterol 2008 1.10
67 Fim operon variation in the emergence of Enterohemorrhagic Escherichia coli: an evolutionary and functional analysis. FEMS Microbiol Lett 2007 1.10
68 Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect Immun 2006 1.10
69 Drug-resistant Escherichia coli, Rural Idaho. Emerg Infect Dis 2005 1.09
70 Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli. J Bacteriol 2012 1.07
71 Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol 2009 1.07
72 Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun 2012 1.06
73 Post-prostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli. J Clin Microbiol 2012 1.06
74 Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio 2011 1.04
75 Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection. J Clin Microbiol 2012 1.02
76 Urinary tract infections. Prim Care 2008 1.02
77 Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother 2012 1.02
78 Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit Rev Ther Drug Carrier Syst 2007 1.01
79 Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City. Diagn Microbiol Infect Dis 2012 1.01
80 Characterization of Stg fimbriae from an avian pathogenic Escherichia coli O78:K80 strain and assessment of their contribution to colonization of the chicken respiratory tract. J Bacteriol 2006 1.00
81 Occurrence of antibiotic-resistant uropathogenic Escherichia coli clonal group A in wastewater effluents. Appl Environ Microbiol 2007 1.00
82 Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics. Chembiochem 2008 0.99
83 Intestinal population dynamics of UTI-causing Escherichia coli within heterosexual couples. Curr Issues Intest Microbiol 2004 0.99
84 Virulence factors predict Escherichia coli colonization patterns among human and animal household members. Ann Intern Med 2004 0.99
85 Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents 2003 0.98
86 A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A. Antimicrob Agents Chemother 2009 0.97
87 S-nitrosylation of syntaxin 1 at Cys(145) is a regulatory switch controlling Munc18-1 binding. Biochem J 2008 0.97
88 Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting. Foodborne Pathog Dis 2009 0.96
89 Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry. Foodborne Pathog Dis 2011 0.96
90 In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe. Mol Pharm 2011 0.95
91 Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr Infect Dis J 2013 0.95
92 Internet survey of Foley catheter practices and knowledge among Minnesota nurses. Am J Infect Control 2009 0.94
93 Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 2010 0.94
94 Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011 0.94
95 Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J Clin Microbiol 2013 0.94
96 Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon. J Antimicrob Chemother 2014 0.94
97 Synthetic peptides with selective affinity for apoptotic cells. Org Biomol Chem 2006 0.93
98 Cephalosporin-resistant Escherichia coli among summer camp attendees with salmonellosis. Emerg Infect Dis 2003 0.93
99 Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J Infect Dis 2008 0.92
100 Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children. Antimicrob Agents Chemother 2006 0.92
101 Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. J Am Vet Med Assoc 2004 0.91
102 Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Braz J Infect Dis 2012 0.91
103 Multiplex PCR-based reverse line blot assay for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli. Appl Environ Microbiol 2011 0.89
104 Haemolytic Escherichia coli isolated from dogs with diarrhea have characteristics of both uropathogenic and necrotoxigenic strains. Vet Microbiol 2002 0.88
105 Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. Curr Top Med Chem 2013 0.88
106 A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine 2007 0.88
107 Use of a computer decision support system and antimicrobial therapy appropriateness. Infect Control Hosp Epidemiol 2013 0.88
108 Quantum dot probes for bacteria distinguish Escherichia coli mutants and permit in vivo imaging. Chem Commun (Camb) 2008 0.88
109 Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother 2009 0.87
110 Prevalence of avian-pathogenic Escherichia coli strain O1 genomic islands among extraintestinal and commensal E. coli isolates. J Bacteriol 2012 0.87
111 Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. J Antimicrob Chemother 2013 0.86
112 Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients. Antimicrob Agents Chemother 2012 0.86
113 Management of chronic hepatitis B. Evid Rep Technol Assess (Full Rep) 2008 0.86
114 Reservoirs of Extraintestinal Pathogenic Escherichia coli. Microbiol Spectr 2015 0.85
115 Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the United States. FEMS Immunol Med Microbiol 2004 0.85
116 Foley catheter practices and knowledge among Minnesota physicians. Am J Infect Control 2010 0.83
117 PKC-2 phosphorylation of UNC-18 Ser322 in AFD neurons regulates temperature dependency of locomotion. J Neurosci 2012 0.83
118 Foodborne illness acquired in the United States. Emerg Infect Dis 2011 0.83
119 Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2003 0.83
120 The effect of fentanyl on the end-tidal sevoflurane concentration needed to prevent motor movement in dogs. Vet Anaesth Analg 2013 0.83
121 Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection. J Gen Intern Med 2011 0.82
122 Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004 0.82
123 Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis 2005 0.82
124 Escherichia coli ST131: variations on a theme of clonal expansion. Enferm Infecc Microbiol Clin 2013 0.81
125 A survey of resident physicians' knowledge regarding urine testing and subsequent antimicrobial treatment. Am J Infect Control 2013 0.81
126 Structure-function study of mammalian Munc18-1 and C. elegans UNC-18 implicates domain 3b in the regulation of exocytosis. PLoS One 2011 0.81
127 Fluoroquinolone-resistant extraintestinal Escherichia coli clinical isolates representing the O15:K52:H1 clonal group from humans and dogs in Australia. Comp Immunol Microbiol Infect Dis 2012 0.81
128 Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004 0.81
129 Antimicrobial urinary catheters: a systematic review. Expert Rev Med Devices 2008 0.80
130 Identification of key structural elements for neuronal calcium sensor-1 function in the regulation of the temperature-dependency of locomotion in C. elegans. Mol Brain 2013 0.80
131 Presynaptic targets for acute ethanol sensitivity. Biochem Soc Trans 2010 0.80
132 Colonisation dynamics and virulence of two clonal groups of multidrug-resistant Escherichia coli isolated from dogs. Microbes Infect 2008 0.80
133 Purple urine bag syndrome. JAMA 2012 0.79
134 Escherichia coli clonal group A. Clin Infect Dis 2005 0.79
135 Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. J Clin Gastroenterol 2016 0.79
136 Issues and challenges in developing long-acting veterinary antibiotic formulations. Adv Drug Deliv Rev 2004 0.78
137 Long-acting injectable hormonal dosage forms for contraception. Pharm Res 2015 0.78
138 Urine cultures among hospitalized veterans: casting too broad a net? Infect Control Hosp Epidemiol 2014 0.78
139 Principles of judicious antibiotic use: nonspecific upper respiratory tract infections. Ann Intern Med 2002 0.77
140 Virulence factors in Escherichia coli. J Clin Microbiol 2005 0.77
141 Appropriateness of urinary tract infection diagnosis and treatment duration. Arch Intern Med 2010 0.77
142 Facilitated phospholipid translocation in vesicles and nucleated cells using synthetic small molecule scramblases. Bioorg Med Chem 2008 0.77
143 Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, Minnesota. Infect Control Hosp Epidemiol 2014 0.77
144 Reduction of nephrotoxicity associated with amphotericin B deoxycholate. Clin Infect Dis 2004 0.77
145 Pokes, pathogens, and primum non nocere: prudent prophylaxis protocols for prostate biopsy. Infect Control Hosp Epidemiol 2013 0.77
146 Prediction of dissolution profiles of acetaminophen beads using artificial neural networks. Pharm Dev Technol 2006 0.77
147 Extended-spectrum β-lactamase-producing Escherichia coli in neonatal care unit. Emerg Infect Dis 2011 0.77
148 Persistent Staphylococcus aureus bacteremia. Arch Intern Med 2008 0.77
149 Molecular Epidemiology of Extraintestinal Pathogenic Escherichia coli. Ecosal Plus 2004 0.76
150 Controlled release of oxytetracycline in sheep. J Control Release 2002 0.76
151 Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review. Diagn Microbiol Infect Dis 2008 0.76
152 NMR structure of Hsp12, a protein induced by and required for dietary restriction-induced lifespan extension in yeast. PLoS One 2012 0.76
153 Hydrocortisone and treatment of multiple trauma. JAMA 2011 0.75
154 Rifapentine and isoniazid for latent tuberculosis. N Engl J Med 2012 0.75
155 Vancomycin levels, efficacy, and toxicity. Arch Intern Med 2007 0.75
156 Hospital-onset infections: a patient safety issue. Ann Intern Med 2003 0.75
157 Fluoroquinolone-resistant extraintestinal pathogenic Escherichia coli, including O25b-ST131, isolated from faeces of hospitalized dogs in an Australian veterinary referral centre. J Antimicrob Chemother 2013 0.75
158 Principles of judicious antibiotic use: acute rhinosinusitis. Ann Intern Med 2002 0.75
159 Assessment of patients with chest pain. Ann Intern Med 2004 0.75
160 Prevention of antibiotic resistance in hospitals. Ann Intern Med 2002 0.75
161 Evaluation of fluorescent phosphatidylserine substrates for the aminophospholipid flippase in mammalian cells. J Fluoresc 2011 0.75
162 Escherichia coil cluster evaluation. Emerg Infect Dis 2007 0.75
163 Re: Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med 2012 0.75
164 Appropriateness of fluoroquinolones for therapy of urinary tract infection. Arch Intern Med 2003 0.75
165 Wait-and-see prescription for acute otitis media. JAMA 2007 0.75
166 Comparing costs and quality of care at retail clinics with those of other medical settings. Ann Intern Med 2010 0.75
167 Practical aspects of choosing antibiotic therapy for patients with a reported antibiotic allergy. Clin Infect Dis 2002 0.75
168 Case 28-2002: a traveler with a rapidly progressive soft-tissue infection. N Engl J Med 2003 0.75
169 Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection. Ann Intern Med 2006 0.75
170 Safety of urinary catheters. JAMA 2003 0.75
171 Escherichia coli pathogenicity island-like domains. Infect Immun 2002 0.75
172 Voriconazole versus liposomal amphotericin B for empirical antifungal therapy. N Engl J Med 2002 0.75
173 Rifampin and methicillin-resistant Staphylococcus aureus bone and joint infections. Clin Infect Dis 2011 0.75
174 Multiple blood cultures for diagnosing bacteremia. Clin Infect Dis 2003 0.75
175 Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003 0.75
176 Clonal identity of Escherichia coli as a predictive factor for recurrent cystitis. Virulence 2011 0.75
177 Do not abandon cultures. Arch Intern Med 2011 0.75
178 Reinfection versus relapse in urinary tract infection. Clin Infect Dis 2005 0.75
179 Post-translational and transcriptional regulation of glycolipid glycosyltransferase genes in apoptotic breast carcinoma cells: VII. Studied by DNA-microarray after treatment with L-PPMP. Glycoconj J 2009 0.75
180 Regulation of glycosyltransferase genes in apoptotic breast cancer cells induced by L: -PPMP and cisplatin. Adv Exp Med Biol 2011 0.75
181 Dedicated catheter lumens for parenteral nutrition. Clin Infect Dis 2003 0.75
182 A novel, biodegradable and reversible polyelectrolyte platform for topical-colonic delivery of pentosan polysulphate. Int J Pharm 2010 0.75